Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial.

ABSTRACT:

Aims

Digital therapeutics is a new approach to facilitate the non-pharmacological treatment of hypertension using software programmes such as smartphone applications and/or device algorithms. Based on promising findings from a small pilot trial, the HERB Digital Hypertension 1 (HERB-DH1) pivotal trial investigated the efficacy of digital therapeutics in patients with hypertension not receiving antihypertensive medication.

Methods and results

This prospective, open-label, randomized controlled study was performed at 12 sites in Japan. Patients with hypertension [office systolic blood pressure (SBP) 140 to <180 mmHg and 24 h SBP ≥130 mmHg] were randomly assigned 1:1 to the digital therapeutics group (HERB system + standard lifestyle modification) or control group (standard lif

SUBMITTER: Kario K 

PROVIDER: S-EPMC8530534 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature